In patients with AD complicated with different degrees of inflammatory reactions, inflammatory factors will accumulate in the tissues around the lesions, affect the metabolism of healthy cells, cause death of numerous healthy cells, and the functions of cranial neurons themselves will be seriously affected; therefore, the degree of cognitive dysfunction in patients with AD can be assessed by CRP. This evidence concerns the gene CRP and Alzheimer disease.